Overview

Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

Status:
Completed

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

Summary

Study N01175 was to compare overall effectiveness (efficacy and safety) of levetiracetam (LEV) versus the 2 older antiepileptic drugs (AEDs), sodium valproate extended release (VPA-ER) and carbamazepine controlled release (CBZ-CR) in the treatment of subjects with newly diagnosed epilepsy.

Phase:

Phase 3

Details

Lead Sponsor:

UCB Pharma

Treatments:

Carbamazepine
Etiracetam
Levetiracetam
Piracetam
Valproic Acid